Serine/threonine‐protein kinase D2 ‐mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression
The Journal of Pathology · 2024
DOI: 10.1002/path.6264 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2024. Verfasst von Yin-Qiao Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, PR China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Education of Guangdong Province, The Natural Science Foundation of Guangdong Province-Outstanding Youth Project.
Abstract (Originalsprache)
Desmoglein‐2 (DSG2) is a transmembrane glycoprotein belonging to the desmosomal cadherin family, which mediates cell–cell junctions; regulates cell proliferation, migration, and invasion; and promotes tumor development and metastasis. We previously showed serum DSG2 to be a potential biomarker for the diagnosis of esophageal squamous cell carcinoma (ESCC), although the significance and underlying molecular mechanisms were not identified. Here, we found that DSG2 was increased in ESCC tissues compared with adjacent tissues. In addition, we demonstrated that DSG2 promoted ESCC cell migration and invasion. Furthermore, using interactome analysis, we identified serine/threonine‐protein kinase D2 (PRKD2) as a novel DSG2 kinase that mediates the phosphorylation of DSG2 at threonine 730 (T730). Functionally, DSG2 promoted ESCC cell migration and invasion dependent on DSG2‐T730 phosphorylation. Mechanistically, DSG2 T730 phosphorylation activated EGFR, Src, AKT, and ERK signaling pathways. In addition, DSG2 and PRKD2 were positively correlated with each other, and the overall survival time of ESCC patients with high DSG2 and PRKD2 was shorter than that of patients with low DSG2 and PRKD2 levels. In summary, PRKD2 is a novel DSG2 kinase, and PRKD2‐mediated DSG2 T730 phosphorylation promotes ESCC progression. These findings may facilitate the development of future therapeutic agents that target DSG2 and DSG2 phosphorylation. © 2024 The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, PR China.
- Department of Clinical Laboratory Medicine, The Cancer Hospital of Shantou University Medical College, Shantou, PR China.
- Department of Oncological Laboratory Research, The Cancer Hospital of Shantou University Medical College, Shantou, PR China.
- Institute of Oncologic Pathology, Shantou University Medical College, Shantou, PR China.
- Shantou Academy Medical Sciences, Shantou, PR China.
ORCID-Profile: En-Min Li, Wang-Kai Fang
Förderung
- National Natural Science Foundation of China
- Department of Education of Guangdong Province
- The Natural Science Foundation of Guangdong Province-Outstanding Youth Project
Zitieren
APA
Liu, Y. Q., Xu, Y. W., Zheng, Z. T., Li, D., Hong, C. Q., Dai, H. Q., Wang, J. H., Chu, L. Y., Liao, L. D., Zou, H. Y., Li, E. M., Xie, J. J., & Fang, W. K. (2024). Serine/threonine‐protein kinase D2 ‐mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression. The Journal of Pathology. https://doi.org/10.1002/path.6264
Vancouver
Liu YQ, Xu YW, Zheng ZT, Li D, Hong CQ, Dai HQ, et al. Serine/threonine‐protein kinase D2 ‐mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression. The Journal of Pathology. 2024. doi:10.1002/path.6264
BibTeX
@article{Liu2024,
author = {Liu, Yin-Qiao and Xu, Yi-Wei and Zheng, Zheng-Tan and Li, Die and Hong, Chao-Qun and Dai, Hao-Qiang and Wang, Jun-Hao and Chu, Ling-Yu and Liao, Lian-Di and Zou, Hai-Ying and Li, En-Min and Xie, Jian-Jun and Fang, Wang-Kai},
title = {Serine/threonine‐protein kinase D2 ‐mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression},
journal = {The Journal of Pathology},
year = {2024},
doi = {10.1002/path.6264}
}
EUVIMED